Sinopharm Tech Holdings Limited reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was HKD 9.4 million compared to HKD 10.05 million a year ago. Net income was HKD 11.03 million compared to net loss of HKD 4.11 million a year ago. Basic earnings per share from continuing operations was HKD 0.06 compared to basic loss per share from continuing operations of HKD 0.0225 a year ago.
For the six months, sales was HKD 15.03 million compared to HKD 11.73 million a year ago. Net income was HKD 15.41 million compared to net loss of HKD 13.5 million a year ago. Basic earnings per share from continuing operations was HKD 0.085 compared to basic loss per share from continuing operations of HKD 0.075 a year ago.